Abstract: A zonal isolation device conveyed into the wellbore with a propped flapper valve. The zonal isolation device comprises a deformable sealing element and a support ring movably disposed within the inner bore of the sealing element. A flapper valve coupled to the support ring is configured to engage a sealing surface of support ring. The flapper valve blocks fluid flow through the zonal isolation device in a fully closed position, allows unrestricted fluid flow through the zonal isolation device in a fully open position, and allows restricted fluid flow through the zonal isolation device when held by a propping component in an intermediate or partially open position. The zonal isolation device is anchored to the wellbore by an anchoring assembly engaged with a wedge coupled to the downhole end of the sealing element.

Abstract: A food thawing apparatus includes a cabinet structure defining a thawing chamber accessible by at least one door, and a plurality of air movers and associated air flow structure configured for causing air flow through the thawing chamber such that multiple air flow circuits are set up within the cabinet structure. The cabinet structure defines a vertically extending flow section alongside the thawing chamber. A refrigeration system includes a condenser section and an evaporator section. In one example, the multiple air flow circuits include: a first air flow circuit that runs through the flow section, into and through the thawing chamber, into and through the evaporator section and back to the flow section; and a second air flow circuit from the flow section, through a first set of the plurality of shelves and back to the flow section, without passing through the evaporator section.

Abstract: Gamma brain stimulation for preventing or treating Alzheimer's disease or sleeping disorders using light or sound is known. A strobing 40 Hz light source has been shown to cause positive effects due to the stimulation. It is an advantage to know the actual dosage of light that enters the person's eyes in order to understand the relationship between dosage and effectiveness. A camera is used to detect the subject's gaze angle, distance, pupil diameter and any other factors that affect the light power that enters the eye. A target dosage is first determined by a medical worker, such as to determine the effects of the exact same dosage on a group persons, such as Alzheimer's patients. With deviations of gaze angle, distance, and pupil size from the ideal, the effective dosage is decreased. The disclosed system adjusts the actual dosage, such as session duration, based on such factors so that the final dosage received by the person is consistent and meets the target dosage.

Abstract: A reference signal generator (1) generates a reference signal (REF) having high auto-correlation. A delay unit (2) delays the reference signal (REF) to generate delayed reference signals and outputs the reference signal (REF) and the delayed reference signals to the transmission units (TR1-TRN), respectively. A calibration network (3) combines the output signals of the transmission units (TR1-TRN). An analyzer (4) analyzes a correlation between a demodulated signal (DEM) and the reference signal (REF) to determine variations of timing, amplitude and a phase of the output signal of each transmission unit. Each transmission unit calibrates the timing, amplitude and phase of the output signal based on a corresponding determination result.

Abstract: A window mill is positionable in a wellbore having an annulus. The window mill includes a mill body having an outer surface, a conduit extending axially through the mill body, and a flow port extending from the conduit through the outer surface. A nozzle shuttle including a nozzle is arranged in the conduit. The nozzle shuttle selectively extending over the flow port. A selectively openable port adapter extends between the flow port and the nozzle shuttle. The selectively openable port adapter is responsive to fluid pressure to fluidically expose the conduit to the annulus through the flow port.

Abstract: Disclosed herein are systems, methods, and devices for transaction methods for mobile wallet operations in a casino. Various embodiments are directed to applying funds to a user's mobile wallet by transactions at a kiosk, cage, Peripheral System, or other system of the casino. Embodiments are also directed to applying credit to an electronic gaming machine of the casino. Embodiments are also directed to returning or redeeming credit from an electronic gaming machine of the casino to the user. Embodiments are also directed to transferring credit from a mobile wallet to external funds.

Abstract: An optical scanning system including a radiating source that outputs a light beam, a time varying beam reflector that reflects the light beam through a scan lens towards a transparent sample at an incident angle of plus or minus ten degrees from Brewster's angle, a focusing lens configured to be irradiated by light scattered from the transparent sample, and a detector that is irradiated by the light scattered from the transparent sample. The detector outputs a signal that indicates an intensity of light measured by the detector. None of the light scattered from the transparent sample is blocked. The light scattered from the transparent sample is scattered from the top surface of the transparent sample, the bottom surface of the transparent sample, or any location in between the top surface of the transparent sample and the bottom surface of the transparent sample.

Abstract: A method for producing an organic non-fullerene electron transport compound includes mixing naphthalene-1,4,5,8-tetracarboxylic dianhydride and an amine compound in dimethylformamide. The method also includes heating the mixture to a temperature greater than or equal to 70° and less than or equal to 160° C. for an amount of time greater than or equal to 1 hour and less than or equal to 24 hours. The method further includes isolating an organic non-fullerene electron transport compound reaction product.

Abstract: The present invention is relates to a compound of formula (I), wherein X1, X2 and X3 are, independently of each other, N or CH; with the proviso that at least two of X1, X2 and X3 are N; Y is N or CH; R1 and R2 are independently of each other (iii) a morpholinyl of formula (II) wherein the arrow denotes the bond in formula (I); and wherein R3 and R4 are independently of each other H, C1-C3alkyl optionally substituted with one or two OH, C1-C2fluoroalkyl, C1-C2alkoxy, C1-C2alkoxyC1-C3alkyl, CN, or C(O)O—C1-C2alkyl; or R3 and R4 form together a bivalent residue —R5R6— selected from C1-C3alkylene optionally substituted with 1 to 4 F, —CH2—O—CH2—, —CH2—NH—CH2—, or any of the structures wherein the arrows denote the bonds in formula (II); or (iv) a saturated 6-membered heterocyclic ring Z selected from thiomorpholinyl and piperazinyl, optionally substituted by 1 to 3 R7; wherein R7 is independently at each occurrence C1-C3alkyl optionally substituted with one or two OH, C1-C2fluoroalkyl,

Abstract: A plasma chamber includes a chamber body having a processing region therewithin, a liner disposed on the chamber body, the liner surrounding the processing region, a substrate support disposed within the liner, a magnet assembly comprising a plurality of magnets disposed around the liner, and a magnetic-material shield disposed around the liner, the magnetic-material shield encapsulating the processing region near the substrate support.

Abstract: The present invention relates to a method for estimating the effectiveness of treatment with an anti-CD20 agent in a patient with rheumatoid arthritis and who has had an inadequate response to at least one prior biotherapy, consisting in analysing a biological sample of said patient for the expression of a set of biomarkers, the results of which make it possible to determine whether said agent is a treatment that will engender a beneficial response for said patient. The present invention also relates to a system for estimating the effectiveness of said treatment in said patient comprising means for measuring or receiving data, the expression level of said biomarkers and means for processing these data configured to estimate said effectiveness of said treatment in said patient.

Abstract: The present invention provides triazolone compounds of general formula (I): in which R1, R2, R3, R4, and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment and prophylaxis of diseases, in particular hyperproliferative disorders, as a sole agent or in combination with other active ingredients.

Abstract: A system for facilitating acquisition of items on behalf of a requesting device is provided. The system comprises an application that when executed on a computer publishes a listing of items specified by a first device, the items available from online vendors designated in the specification. The system also receives an instruction from a second device to purchase a first item in the listing of items. The system also purchases, based on the instruction, the first item from a first online vendor of the online vendors, and directs the first online vendor to ship the first item to a specified address. The specified address is provided by the first device. The system further verifies availability and price of the first item with the first online vendor prior to purchasing.

Abstract: A method for operating an electronic device includes transmitting signals to an external electronic device. The method also includes receiving signals from the external electronic device. The method further includes generating location information of the external electronic device relative to the electronic device based on a differences between the transmitted signals and the received signals. Additionally, the method includes determining an action for changing a state on at least one of the electronic device or the external electronic device based on the location information. In response to determining that the action is associated with the electronic device, the method includes performing the action. In response to determining that the action is associated with the external electronic device, method includes sending an instruction to the external electronic device to perform the action.

Abstract: Provided is a high entropy composite oxide of formula ([M1]pMnqFexCryNiz)3O4 having a spinel crystal, wherein the [M1], p, q, x, y and z are as defined in the specification. A method for producing the high entropy composite oxide, and anode materials including the same are further provided. With the entropy stabilization effect and plenty of oxygen vacancies, the anode materials including the high entropy composite oxide show the advantage of high Li+ transport rate, high electric capacity, redox durability, and good cycling stability, thereby having a bright prospect for application.

Abstract: Multiple polynucleotides having different, arbitrary sequences are synthesized on the surface of an array by spatial control of polymerase activity. The polymerase is a template-independent polymerase such as terminal deoxynucleotidyl transferase (TdT). Spatial control of polymerase activity is implemented by localized changes in redox-pH conditions. A single species of nucleotide is added and incorporated on growing polynucleotide strands at locations on the array where the polymerase is active. A washing step removes the polymerase and free nucleotides. This process may be repeated multiple times changing both the location of polymerase activity and the species of nucleotide thereby synthesizing different polynucleotides in parallel on the surface of the array. Polymerase activity may be regulated by removing a blocking group attached to a His-tag sequence on the polymerase, a change in pH, or release of encapsulated inhibitors.

Abstract: An organic light emitting diode display according to an exemplary embodiment includes: a substrate; a first buffer layer on the substrate; a first semiconductor layer on the first buffer layer; a first gate insulating layer on the first semiconductor layer; a first gate electrode and a blocking layer on the first gate insulating layer; a second buffer layer on the first gate electrode; a second semiconductor layer on the second buffer layer; a second gate insulating layer on the second semiconductor layer; and a second gate electrode on the second gate insulating layer.

Abstract: An apparatus for optical processing of a signal includes an optical sampler, an optical neural network and a phase shift controller. The optical sampler obtains parallel optical samples by sampling a continuous optical signal. The optical neural network optically processes the parallel optical samples and provides a final output optical signal resulting from the processing. The optical neural network includes interconnected optical neurons. Each of the optical neurons inputs multiple optical signals and outputs an optical signal which is a weighted sum of the input optical signals. The weightings are established by phase-shifting the input optical signals prior to the summation. The phase shift controller controls the phase-shifting so as to obtain required weightings for the input optical signals.

Abstract: A device may receive activity data identifying activities of a process performed by users via user devices. The device may receive baseline data identifying baselines associated with the process and variant data identifying variants from the baselines. The device may apply a sequence alignment model, to the activity data and the baseline data, to determine first similar sequences associated with the activities and the baselines and may apply the sequence alignment model, to the activity data and the variant data, to determine second similar sequences associated with the activities and the variants. The device may determine, based on the first similar sequences, first label data identifying first labels for the activities and may determine, based on the second similar sequences, second label data identifying second labels for the activities. The device may generate a process diagram based on the activity data, the first label data, and the second label data.

Abstract: Bayesian continuous user authentication can be obtained by receiving observed behavior data that collectively characterizes interaction of an active user with at least one computing device or software application. A sequence of events within the observed behavior data can be identified and scored using a universal background model that generates first scores that characterize an extent to which each event or history of events is anomalous for a particular population of users. Further, the events are scored using a user model that generates second scores that characterizes an extent to which each event or history of events is anomalous for the particular user who owns the account. The first scores and the second scores are smoothed using a smoothing function. A probability that the active user is the account owner associated with the user model is determined based on the smoothed first scores and the smoothed second scores.